Novel strategies exploiting interleukin-12 in cancer immunotherapy-Reference-Cited by-同舟云学术

Novel strategies exploiting interleukin-12 in cancer immunotherapy

Published:2022-11 Issue: Volume:239 Page:108189
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Cirella Assunta,Luri-Rey Carlos,Di Trani Claudia Augusta,Teijeira Alvaro,Olivera Irene,Bolaños Elixabet,Castañón Eduardo,Palencia Belen,Brocco Davide,Fernández-Sendin Myriam,Aranda Fernando,Berraondo Pedro,Melero Ignacio

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference159 articles.

1. Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity;Agarwal;Nature Biomedical Engineering,2022

2. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17;Aggarwal;The Journal of Biological Chemistry,2003

3. Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma;Agliardi;Nature Communications,2021

4. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients;Algazi;Annals of Oncology : Official Journal of the European Society for Medical Oncology,2020

5. Phase II trial of IL-12 plasmid transfection and PD-1 blockade in immunologically quiescent melanoma;Algazi;Clinical Cancer Research: An Official Journal of the American Association for Cancer Research,2020

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional and intratumoral adoptive T-cell therapy;Immuno-Oncology and Technology;2024-12

2. Dihydroxyphenylalanine-conjugated high molecular weight polyethylenimine for targeted delivery of Plasmid;Scientific Reports;2024-09-04

3. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

4. Immunostimulatory CKb11 gene combined with immune checkpoint PD-1/PD-L1 blockade activates immune response and simultaneously overcomes the immunosuppression of cancer;Bioactive Materials;2024-09

5. IL‐12 minicircle delivery via extracellular vesicles as immunotherapy for bladder cancer;Cell Proliferation;2024-08-28